NCT07243899 2025-11-24
Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy
Shanghai Zhongshan Hospital
Completed
Clinical Trials
18 trialsNCT05058560 2025-03-13
Tislelizumab in Addition to BACE in Patients with NSCLC
The First Affiliated Hospital of Zhengzhou University
Phase 2 Completed
NCT04691388 2024-12-05
A Trial of Sintilimab Plus Anlotinib For Metastatic NSCLC After First-Line PD-1 Inhibitor
Zhejiang Cancer Hospital
Phase 2 Completed
NCT03810066 2024-05-09
Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)
University Hospital, Essen
Phase 2 Completed
NCT02869685 2024-02-23
RadImm02
Xinqiao Hospital of Chongqing
Phase NA Completed
NCT02890849 2024-02-23
RadImm01
Xinqiao Hospital of Chongqing
Phase NA Completed
NCT03513666 2023-08-23
JS001
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Completed
NCT04871997 2022-10-21
A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)
Tongji Hospital
Completed
NCT05034445 2021-09-05
Whether Sputum Can Serve as an Alternative Source for Liquid Biopsy in Patients With Lung Cancer
Guangzhou Institute of Respiratory Disease
Completed
NCT03394118 2021-04-27
TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy
Asan Medical Center
Phase 2 Completed
NCT04858204 2021-04-26
IMMUNOBZH
University Hospital, Brest
Completed
NCT01941654 2020-06-18
ATOM_local Ablative Therapy
Chinese University of Hong Kong
Phase 2 Completed
NCT01859650 2019-09-26
HeXeRT
Sheffield Teaching Hospitals NHS Foundation Trust
Completed
NCT02029222 2019-09-04
Photon Versus Particle Therapy for Recurrent Lung Cancer; a Planning Study Based on a Reference Dataset of Patients.
Maastricht Radiation Oncology
Completed
NCT03609918 2018-08-07
Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing
Tianjin Medical University Cancer Institute and Hospital
Completed
NCT02315053 2017-10-27
PET Response During Chemoradiation of Lung Cancer
The Netherlands Cancer Institute
Phase NA Completed
NCT01769066 2016-02-23
Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC
Fudan University
Phase 2/3 Completed
NCT00298415 2013-10-25
Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)
Intergroupe Francophone de Cancerologie Thoracique
Phase 3 Completed